| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
IT:DIA
DiaSorin S.p.A.
|
Jun 17, 2026 | SELL |
Hold
+58.9% avg upside
9 analysts
|
$58.00
10.95% Downside
|
· |
|
FR:BIM
bioMerieux
|
Jun 17, 2026 | HOLD |
Buy
+53.7% avg upside
12 analysts
|
$78.00
13.07% Upside
|
· |
|
QGEN
Qiagen
|
Jun 17, 2026 | BUY |
Buy
+14.1% avg upside
23 analysts
|
— | · |
|
DE:RDC
Redcare Pharmacy
|
Jun 16, 2026 | BUY |
Strong Buy
+38.5% avg upside
7 analysts
|
$102.00
53.68% Upside
|
· |
|
DE:SBS
STRATEC Biomedical
|
May 12, 2026 | HOLD |
Strong Buy
+228.6% avg upside
5 analysts
|
$21.00
15.44% Upside
|
· |
|
CH:TECN
Tecan Group AG
|
Apr 27, 2026 | HOLD |
Buy
+110.4% avg upside
8 analysts
|
$138.00
9.02% Downside
|
· |
|
CH:DOCM
DocMorris
|
Apr 17, 2026 | HOLD |
Hold
-1.4% avg upside
8 analysts
|
$4.50
44.84% Downside
|
· |
|
CH:GALE
Galenica AG
|
Jul 04, 2025 | HOLD |
Hold
-0.2% avg upside
3 analysts
|
$78.00
7.29% Downside
|
· |
|
DE:BNN
B.R.A.I.N. Biotechnology Research and Information Network
|
May 06, 2025 | BUY |
Strong Buy
+194.9% avg upside
3 analysts
|
$8.00
175.86% Upside
|
· |
|
IT:G
Assicurazioni Generali S.p.A.
|
Mar 13, 2024 | HOLD |
Buy
-15.4% avg upside
15 analysts
|
$19.50
54.23% Downside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.